Multicenter US Clinical Evaluation of Minimally Invasive Targeted RF Ablation of Metastatic Spinal Tumors Using a Novel Bipolar Navigational Device

Abstract

Listen

Translate article

Approximately 85% of patients with advance cancer will develop bony metastasis as their disease progress. Nearly three-fourth of these will involve the axial skeleton, thus increasing the risk of bone pain, pathologic vertebral fractures, and compression of neural elements. Increased morbidity and mortality have been associated with patients who are bed-ridden due to pain or neurologic deficit. Therapeutic goals are pain control, spinal stabilization, reducing risk of spinal cord compression, and tumor control.